The global digital pathology market for the historical period 2017–2018 and forecast period 2019–2027, rising awareness about digital pathology and increase in demand for advanced technology are the factors likely to boost the growth of digital pathology market. Moreover, high incidence and prevalence of cancer and other chronic diseases is poised to escalate the growth of digital pathology market.
According to the report, the global digital pathology market was valued at US$ 0.38 Bn in 2018 and is anticipated to expand at a CAGR of over 12.0% from 2019 to 2030
Get the sample copy of report@ https://qyresearchmedical.com/sample/111660
Key Drivers of Global Digital Pathology Market
Cancer is emerging as crucial public health problem worldwide and it is unconquered. World Health Organization states that, in 2018, estimated 9.6 million deaths and 18.1 million new cases of cancer were recorded globally
There is an increase in the number of cancer cases due to growing elderly population globally coupled with unhealthy lifestyles. According to Cancer Facts & Figures 2019, estimated number of older adults, aged 85 years and above was 6.4 million in 2016 and it is expected to reach 19.0 million by 2060. In 2019, 1,944,280 adults aged 85 and older were alive with a history of cancer
Breast, lung and prostate cancers are the most frequently diagnosed types of cancer in industrialized countries such as the U.S., U.K. and Japan. Hence, increasing incidences of cancer accentuates the uptake of digital pathology systems market during the study period. This in turn is projected to boost the growth of global digital pathology market.
Preclinical studies using animal model and clinical trials play an important role assessing the safety and efficacy of the drugs. Digital pathology aids in minimizing the error rate, storage of the drug data, also the integration of the data in electronic health records (EHRs), and evaluation of the patient’s response to a particular drug etc.
Rising focus on research and development for drug development and drug discoveries is leading to surge in number of clinical and preclinical trials which is augmenting the growth of global digital pathology market. Furthermore, rise in number of research conducted in academics and research institutes is likely to augment the growth of market.
Technological Advancements Propel Global Digital Pathology Market Growth
Manual interpretation of tissue slides for disease diagnosis purpose is costly and labor extensive that increases error and inconsistency in the diagnostic result and it increases the risk of diagnostic failure and impedes decision making process.
Technological advancements in digital pathology helps to overcome limitation as these systems provide efficient and effective results of diagnostic tests.
Moreover, digital pathology systems can analyze large array of slides within short duration without any diagnostic error. These factors collectively account for the global market demand of digital pathology systems during the forecast period
View full report@ https://qyresearchmedical.com/report/digital-pathology-market-product-type-image-analysis-software-and-scanners-end-use-diagnostic-laboratories-academic-and-research-centers-pharmaceutical-companies-applications-diagnosis-consulting-service-019-2030/111660
High Cost of the System to Hamper Global Digital Pathology Market
High cost associated with technologically advanced digital pathology system is expected to restrain the growth of digital pathology market. For instance, the average cost of the digital pathology systems for telepathology and whole slide imaging is between US$ 30 000 and US$ 300 000, which can be unaffordable for many low resource environment in developing countries
In addition to the cost, the digital pathology systems require costly infrastructure such as larger memory to store data, thereby restricting the usage of digital pathology system this is leading to restraining the growth of global digital pathology market
Stringent Regulations to Restrain Global Digital Pathology Market
Slide scanners and whole slide imaging devices are involved in the digital pathology systems for diagnostic purpose and these devices require the regulatory approval before commercialization.
In addition, in the U.S. market, clinical laboratories have to meet the criteria and standards of Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologist (CAP) pertaining to the utilization of digital pathology.
Few CLIA regulations are required to be considered for implementing a digital pathology system for diagnosis purpose such as Section 493.1251 (procedure manual), Section 493.1252 (test systems, equipment, instruments) and Section 493.1253 (establishment and verification of performance).
Such regulations imposed by agencies such as FDA, CLIA and CAP on digital pathology systems, manufacturers experience a tough phase throughout the approval process and commercialization of their products, which restrains the growth of the global digital pathology market
Global Digital Pathology Market: Competitive Landscape
This report profiles major players in the global digital pathology market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
The global digital pathology market is highly fragmented, with the presence of a number of international as well as regional players
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111660/2900
Leading players operating in the global digital pathology market are
- Leica Biosystems Imaging, Inc
- OLYMPUS CORPORATION
- F. Hoffmann-La Roche Ltd
- Mikroscan Technologies, Inc.
- Koninklijke Philips N.V.
- Sectra AB and Inspirata
Global Digital Pathology Market: Key Developments
Key players in the global digital pathology market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global digital pathology market. A few expansion strategies adopted by players operating in the global digital pathology market are:
In February 2019, Neuberg Diagnostics and OptraSCAN Inc. announced the launch of Global TELEPath Network for the pathologist community in UAE, India and South Africa under a new joint venture namely Neuberg DIGIPATH. This is enabled to increase focus on providing advanced and affordable digital pathology solutions
In March 2018, F. Hoffmann-La Roche Ltd announced the launch of VENTANA DP 200 slide scanner for digital pathology. The slide scanner is high speed and produces images with high image quality. The launch of the product will broaden the product portfolio of the company and strengthen its position in digital pathology market.
In January 2018, Inspirata announced that it has acquired the company Omnyx from GE healthcare. The acquisition of the company will ensure that Inspirata has the one of the most comprehensive digital pathology solution work flow
The report on the global digital pathology market discussed individual strategies, followed by company profiles of manufacturers of digital pathology. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global digital pathology market
Key Questions Answered in Global Digital Pathology Market Report
- What is the scope of growth for product companies in the global digital pathology market?
- What will be the Y-o-Y growth of the global digital pathology market between 2019 and 2027?
- What is the influence of changing trends in technologies on the global digital pathology market?
- Will North America continue to be the most profitable market for digital pathology providers?
- Which factors are anticipated to hamper the growth of the global digital pathology market during the forecast period?
- Which are the leading companies in the global digital pathology market?
Global Digital Pathology Market – Segmentation
- Image Analysis Software
- Consulting Services
- Diagnostic Laboratories
- Academic & Research Centers
- Pharmaceutical Companies
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
TABLE OF CONTENT
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Digital Pathology Market
4. Market Overview
4.1.1. Product Type/Definition
4.1.2. Industry Evolution / Developments
4.3. Market Dynamics
4.4. Global Digital Pathology Market Analysis and Forecasts, 2017–2027
5. Key Insights
5.1. Healthcare IT Spending
5.2. Digital Pathology Market Overview
5.3. Epidemiology of Cancer by Country/Sub-region
6. Global Digital Pathology Market Analysis and Forecasts, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Digital Pathology Market Value Forecast by Product Type, 2017–2027
6.3.1. Image Analysis Software
6.4. Global Digital Pathology Market Attractiveness by Product Type
7. Global Digital Pathology Market Analysis and Forecasts, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Digital Pathology Market Value Forecast by End-user, 2017–2027
7.3.1. Diagnostic Laboratories
7.3.2. Academic & Research Centers
7.3.3. Pharmaceutical Companies
7.4. Global Digital Pathology Market Attractiveness by End-user
8. Global Digital Pathology Market Analysis and Forecasts, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Digital Pathology Market Value Forecast by Application, 2017–2027
8.3.2. Consulting Services
8.4. Global Digital Pathology Market Attractiveness by End-user
9. Global Digital Pathology Market Analysis and Forecasts, by Region
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111660/2900
You can place an order or ask any questions, please feel free to contact firstname.lastname@example.org | +1 9197 992 333
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us: